[1]
M. Miñarcaja, A. Estrella, and M. Vallejo Martínez, “End-of-life symptom control with dexmedetomidine: A single-center observational study”., Rev. Oncol. Ecu., vol. 33, no. 2, pp. 143–152, Aug. 2023.